BPC-157 (sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, molecular weight 1419.5 Da) is a stable partial sequence of the gastric protection compound BPC , a protein present in human gastric juice
Studies demonstrate protection against diabetes, obesity, cardiovascular disease, kidney disease, liver disease, neurodegeneration, and cancer through comprehensive metabolic optimization
This compound is handled exclusively in controlled research settings for in vitro and pre-clinical studies, with no applications in human or veterinary medicine
Sikiri, P., Mazul, B., Seiwerth, S., Grabarevi, Z., Rucman, R., Petek, M., Jagi, V., Turkovi, B., Rotkvi, I., Mise, S., Zorici, I., Jurina, L., Konjevoda, P., Hanzevacki, M., Gjurasin, M., Separovi, J., Ljubanovi, D., Artukovi, B., Bratuli, M., Tisljar, M., Sumajstorci, J
For glutathione, it is more on the political side, and the systems are not good enough in those countries to know how to use it properly. If glutathione were not that popular and all the clinics and practitioners followed the guidelines within protocol in other countries, would the FDA ban glutathione